EP3125931A4 - Compositions of multimeric-multiepitope influenza polypeptides and their production - Google Patents
Compositions of multimeric-multiepitope influenza polypeptides and their production Download PDFInfo
- Publication number
- EP3125931A4 EP3125931A4 EP15773045.8A EP15773045A EP3125931A4 EP 3125931 A4 EP3125931 A4 EP 3125931A4 EP 15773045 A EP15773045 A EP 15773045A EP 3125931 A4 EP3125931 A4 EP 3125931A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- multimeric
- compositions
- production
- influenza polypeptides
- multiepitope influenza
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 206010022000 influenza Diseases 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/11—Orthomyxoviridae, e.g. influenza virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201461974449P | 2014-04-03 | 2014-04-03 | |
PCT/IL2015/050354 WO2015151103A1 (en) | 2014-04-03 | 2015-04-01 | Compositions of multimeric-multiepitope influenza polypeptides and their production |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3125931A1 EP3125931A1 (en) | 2017-02-08 |
EP3125931A4 true EP3125931A4 (en) | 2017-09-20 |
Family
ID=54239499
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP15773045.8A Withdrawn EP3125931A4 (en) | 2014-04-03 | 2015-04-01 | Compositions of multimeric-multiepitope influenza polypeptides and their production |
Country Status (8)
Country | Link |
---|---|
US (1) | US10426828B2 (zh) |
EP (1) | EP3125931A4 (zh) |
JP (1) | JP6550072B2 (zh) |
CN (1) | CN106163553B (zh) |
AU (1) | AU2015242154B2 (zh) |
CA (1) | CA2944768C (zh) |
IL (1) | IL248055B (zh) |
WO (1) | WO2015151103A1 (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112019013402A2 (pt) | 2016-12-28 | 2020-03-03 | Invvax, Inc. | Vacinas de influenza |
CN112755012A (zh) * | 2021-01-04 | 2021-05-07 | 福建农林大学 | S-甲基异硫脲硫酸盐在制备抗流感病毒和大肠杆菌共感染药物中的应用 |
CN113004422B (zh) * | 2021-03-04 | 2023-01-20 | 辽宁成大生物股份有限公司 | 一种融合蛋白、含其的疫苗及其应用 |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4767842A (en) | 1973-05-07 | 1988-08-30 | The Ohio State University | Antigenic modification of polypeptides |
US4436727A (en) | 1982-05-26 | 1984-03-13 | Ribi Immunochem Research, Inc. | Refined detoxified endotoxin product |
US4643992A (en) | 1982-11-09 | 1987-02-17 | Scripps Clinic And Research Foundation | Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives |
US4539205A (en) | 1982-11-09 | 1985-09-03 | Scripps Clinic And Research Foundation | Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives |
US5093318A (en) | 1983-11-01 | 1992-03-03 | Scripps Clinic And Research Foundation | Immunostimulating guanosine derivatives and their pharmaceutical compositions |
US5011828A (en) | 1985-11-15 | 1991-04-30 | Michael Goodman | Immunostimulating guanine derivatives, compositions and methods |
US5057540A (en) | 1987-05-29 | 1991-10-15 | Cambridge Biotech Corporation | Saponin adjuvant |
JPH0832638B2 (ja) | 1989-05-25 | 1996-03-29 | カイロン コーポレイション | サブミクロン油滴乳剤を含んで成るアジュバント製剤 |
US5709879A (en) | 1990-06-29 | 1998-01-20 | Chiron Corporation | Vaccine compositions containing liposomes |
GB9326253D0 (en) | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
US6113918A (en) | 1997-05-08 | 2000-09-05 | Ribi Immunochem Research, Inc. | Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors |
US6355257B1 (en) | 1997-05-08 | 2002-03-12 | Corixa Corporation | Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors |
US6303347B1 (en) | 1997-05-08 | 2001-10-16 | Corixa Corporation | Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors |
US6080725A (en) | 1997-05-20 | 2000-06-27 | Galenica Pharmaceuticals, Inc. | Immunostimulating and vaccine compositions employing saponin analog adjuvants and uses thereof |
EP0996451B1 (en) | 1997-05-20 | 2005-01-05 | Galenica Pharmaceuticals, Inc. | Triterpene saponin analogs having adjuvant and immunostimulatory activity |
PT1042001E (pt) | 1997-12-16 | 2002-09-30 | Chiron Corp | Uso de microparticulas combinadas com emulsoes submicronicas oleo-em-agua |
BR9910269A (pt) | 1998-05-07 | 2001-01-09 | Corixa Corp | Composição adjuvante e métodos para seu uso |
US6843781B2 (en) | 1999-10-14 | 2005-01-18 | Becton, Dickinson And Company | Intradermal needle |
AUPQ568100A0 (en) | 2000-02-16 | 2000-03-09 | Amrad Operations Pty. Limited | A method for producing recombinant molecules |
AU2001291049A1 (en) * | 2000-09-15 | 2002-03-26 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, National Institutes Of Health, Office Of Technology Transfer | Defensin-antigen fusion proteins |
DE10053870A1 (de) | 2000-10-31 | 2002-05-08 | Burchardt Elmar Reinhold | Procollagen (III)-Propeptide und verwandte Substanzen zur Behandlung von fibrotischen Erkrankungen |
US20040077540A1 (en) | 2002-06-28 | 2004-04-22 | Nastech Pharmaceutical Company Inc. | Compositions and methods for modulating physiology of epithelial junctional adhesion molecules for enhanced mucosal delivery of therapeutic compounds |
EP2481819A1 (en) * | 2003-02-25 | 2012-08-01 | MedImmune Vaccines, Inc. | Cross flow filtration in the production of stabilized influenza vaccine compositions |
CN1311076C (zh) | 2003-04-16 | 2007-04-18 | 普罗特奥姆技术公司 | 生产重组尿激酶的方法 |
US7108679B2 (en) | 2004-03-11 | 2006-09-19 | Becton, Dickinson And Company | Intradermal syringe and needle assembly |
FR2904219B1 (fr) | 2006-07-28 | 2010-08-13 | Flamel Tech Sa | Microparticules a base de copolymere amphiphile et de principe(s) actif(s) a liberation modifiee et formulations pharmaceutiques en contenant |
EP2019117A1 (en) | 2007-07-27 | 2009-01-28 | BIOPHARM GESELLSCHAFT ZUR BIOTECHNOLOGISCHEN ENTWICKLUNG VON PHARMAKA mbH | Optimized purification process of recombinant growth factor protein |
ES2539818T3 (es) * | 2007-08-02 | 2015-07-06 | Biondvax Pharmaceuticals Ltd. | Vacunas contra la gripe multiepitópicas multiméricas |
US8679344B2 (en) | 2008-12-17 | 2014-03-25 | Cerion Technology, Inc. | Process for solvent shifting a nanoparticle dispersion |
CA2697999C (en) | 2009-04-24 | 2013-04-30 | Werner Hoelke | A stabilized aqueous alpha-galactosidase composition and methods relating thereto |
WO2012054679A1 (en) | 2010-10-20 | 2012-04-26 | Medimmune, Llc | Methods for processing inclusion bodies |
AU2011360572B2 (en) | 2011-02-22 | 2017-03-02 | Biondvax Pharmaceuticals Ltd. | Multimeric multiepitope polypeptides in improved seasonal and pandemic influenza vaccines |
-
2015
- 2015-04-01 JP JP2016559415A patent/JP6550072B2/ja not_active Expired - Fee Related
- 2015-04-01 EP EP15773045.8A patent/EP3125931A4/en not_active Withdrawn
- 2015-04-01 CN CN201580017121.XA patent/CN106163553B/zh not_active Expired - Fee Related
- 2015-04-01 AU AU2015242154A patent/AU2015242154B2/en not_active Ceased
- 2015-04-01 US US15/300,529 patent/US10426828B2/en active Active
- 2015-04-01 WO PCT/IL2015/050354 patent/WO2015151103A1/en active Application Filing
- 2015-04-01 CA CA2944768A patent/CA2944768C/en active Active
-
2016
- 2016-09-26 IL IL248055A patent/IL248055B/en active IP Right Grant
Non-Patent Citations (3)
Title |
---|
ANURAG S. RATHORE ET AL: "Refolding of biotech therapeutic proteins expressed in bacteria: review : Refolding of biotech therapeutic proteins expressed in bacteria", JOURNAL OF CHEMICAL TECHNOLOGY AND BIOTECHNOLOGY, vol. 88, no. 10, 22 July 2013 (2013-07-22), pages 1794 - 1806, XP055396972, ISSN: 0268-2575, DOI: 10.1002/jctb.4152 * |
See also references of WO2015151103A1 * |
TSUMOTO KOUHEI ET AL: "Role of arginine in protein refolding, solubilization, and purification", BIOTECHNOLOGY PROGRESS, AMERICAN INSTITUTE OF CHEMICAL ENGINEERS, US, vol. 20, no. 5, 9 November 2004 (2004-11-09), pages 1301 - 1308, XP002383385, ISSN: 8756-7938, DOI: 10.1021/BP0498793 * |
Also Published As
Publication number | Publication date |
---|---|
CN106163553B (zh) | 2021-07-23 |
IL248055A0 (en) | 2016-11-30 |
AU2015242154A1 (en) | 2016-10-20 |
WO2015151103A1 (en) | 2015-10-08 |
AU2015242154B2 (en) | 2019-04-04 |
CN106163553A (zh) | 2016-11-23 |
JP6550072B2 (ja) | 2019-07-24 |
IL248055B (en) | 2021-02-28 |
CA2944768C (en) | 2022-08-30 |
JP2017509657A (ja) | 2017-04-06 |
US20170173142A1 (en) | 2017-06-22 |
EP3125931A1 (en) | 2017-02-08 |
US10426828B2 (en) | 2019-10-01 |
CA2944768A1 (en) | 2015-10-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1245326A1 (zh) | 用於生產scaav的組合物和方法 | |
EP3129028A4 (en) | Pharmaceutical compositions | |
EP3139920A4 (en) | Anti-viral compounds, pharmaceutical compositions, and methods of use thereof | |
EP3102555A4 (en) | Compositions of compounds and uses thereof | |
EP3131636A4 (en) | Curcumin compositions and uses thereof | |
EP3237890A4 (en) | Triggered assembly of metafluorophores | |
EP3224012A4 (en) | Methods and compositions for concrete production | |
EP3179983A4 (en) | Anti-methanogenic compositions and uses thereof | |
EP3186286A4 (en) | Cellulose-containing compositions and methods of making same | |
EP3240564A4 (en) | Methods of producing long acting ctp-modified polypeptides | |
EP3151678A4 (en) | Soluble protein compositions and methods of their making | |
EP3166892A4 (en) | Scale-inhibition compositions and methods of making and using the same | |
EP3194564A4 (en) | Trichoderma compositions and methods of use | |
EP3136879A4 (en) | Concentrated protein compositions and methods of their making and use | |
EP3160491A4 (en) | Pharmaceutical compositions | |
EP3146038A4 (en) | Formation of multicellular tumoroids and uses thereof | |
EP3190886A4 (en) | Compositions and methods of use thereof | |
EP3237424A4 (en) | Process of making cenicriviroc and related analogs | |
EP3111939A4 (en) | Vitamin d and antibacterial uses of composition thereof | |
EP3137479A4 (en) | Oligonucleotide compositions and methods of making the same | |
EP3197959A4 (en) | Paint formulation and process of making thereof | |
EP3319632A4 (en) | METHODS AND COMPOSITIONS ASSOCIATED WITH INCREASED INFLUENZA VIRUS PRODUCTION | |
EP3166984A4 (en) | Composition and article of manufacture comprising composition | |
HUE049261T2 (hu) | CD44 izolált polipeptidek és alkalmazásaik | |
EP3149026A4 (en) | Site-selective modification of polysaccharides and applications thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20160926 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: GADRI, ZOHAR Inventor name: HASSIN, SHIMON Inventor name: URITSKI, RAM Inventor name: COHEN, BARRY |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: HASSIN, SHIMON Inventor name: URITSKI, RAM Inventor name: GADRI, ZOHAR Inventor name: COHEN, BARRY |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20170821 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 39/145 20060101AFI20170814BHEP Ipc: A61K 9/10 20060101ALI20170814BHEP Ipc: C07K 14/11 20060101ALI20170814BHEP Ipc: A61K 47/18 20170101ALI20170814BHEP |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20200319 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20231101 |